Frankel Martin R, McNaghten Ad, Shapiro Martin F, Sullivan Patrick S, Berry Sandra H, Johnson Christopher H, Flagg Elaine W, Morton Sally, Bozzette Samuel A
Baruch College, The City University of New York, New York City, New York, USA.
Open AIDS J. 2012;6:67-76. doi: 10.2174/1874613601206010067. Epub 2012 Sep 7.
Epidemiologic and clinical changes in the HIV epidemic over time have presented a challenge to public health surveillance to monitor behavioral and clinical factors that affect disease progression and HIV transmission. The Medical Monitoring Project (MMP) is a supplemental surveillance project designed to provide representative, population-based data on clinical status, care, outcomes, and behaviors of HIV-infected persons receiving care at the national level. We describe a three-stage probability sampling method that provides both nationally and state-level representative estimates.In stage-I, 20 states, which included 6 separately funded cities/counties, were selected using probability proportional to size (PPS) sampling. PPS sampling was also used in stage-II to select facilities for participation in each of the 26 funded areas. In stage-III, patients were randomly selected from sampled facilities in a manner that maximized the possibility of having overall equal selection probabilities for every patient in the state or city/county. The sampling methods for MMP could be adapted to other research projects at national or sub-national levels to monitor populations of interest or evaluate outcomes and care for a range of specific diseases or conditions.
随着时间的推移,艾滋病病毒(HIV)疫情的流行病学和临床变化给公共卫生监测带来了挑战,需要监测影响疾病进展和HIV传播的行为及临床因素。医学监测项目(MMP)是一个补充监测项目,旨在提供关于全国范围内接受治疗的HIV感染者的临床状况、治疗、转归及行为的具有代表性的基于人群的数据。我们描述了一种三阶段概率抽样方法,该方法可提供全国和州层面的代表性估计。在第一阶段,使用规模比例概率抽样(PPS)选取了20个州,其中包括6个单独资助的城市/县。第二阶段也采用PPS抽样,为26个资助地区中的每个地区选取参与的机构。在第三阶段,从抽样的机构中随机选取患者,以使该州或城市/县的每个患者总体上具有相等选择概率的可能性最大化。MMP的抽样方法可适用于国家或国家以下层面的其他研究项目,以监测感兴趣的人群或评估一系列特定疾病或状况的转归及治疗情况。